PsyMed Ventures
Overview
PsyMed Ventures invests in transformational technologies that elevate mental health and wellness through it's fund and angel syndicate.
Investment Focus
- Innovative neuroscience and frontier technologies
- Alignment of healing, responsibility, and profitability
Portfolio Companies
Reach PsyMed Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about PsyMed Ventures
What sectors does PsyMed Ventures invest in?
PsyMed Ventures invests in Technology, Healthcare, Artificial Intelligence, Digital Health, Pharmaceuticals and Biotechnology, and is based in United States. PsyMed Ventures is listed as a vc in the ConnectSafely investor database.
What stage does PsyMed Ventures invest at?
PsyMed Ventures backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage.
Which regions does PsyMed Ventures invest in?
PsyMed Ventures invests across United States.
Who are the partners at PsyMed Ventures?
Team members listed for PsyMed Ventures include Matias Serebrinsky (Cofounder and General Partner) and Dina Burkitbayeva (Founder).
What companies has PsyMed Ventures invested in?
PsyMed Ventures's portfolio includes ATAI Life Sciences, Beckley Psytech, Delix Therapeutics, Alto Neuroscience, Freedom Biosciences, Ancilia, Bexson Biomedical and Bloom Science.
How do I contact PsyMed Ventures?
PsyMed Ventures's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
